SciDEX — AAD

Understanding Entity Pages

This page aggregates everything SciDEX knows about AAD: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

Wiki Pages (5)

Outgoing (0)

Target	Relation	Type	Str
No outgoing edges

Incoming (2)

Source	Relation	Type	Str
SMC	associated_with	cell_type	0.72
ANGIOTENSIN_II	causes	protein	0.64

Targeting Hypotheses (0)

Hypothesis	Score	Disease	Analysis
No targeting hypotheses

Hypothesis

Score

Disease

Analysis

No targeting hypotheses

Mentioning Analyses (13)

Is myelin loss in AD causal or an adaptive response to neuronal damage?

neurodegeneration | 2026-04-11 | 0 hypotheses

What is the optimal ketone dosing threshold to avoid metabolic steal syndrome wh

neurometabolism | 2026-04-11 | 0 hypotheses

Do these mechanistic hypotheses from the SEA-AD Atlas bundle explain layer-speci

neurodegeneration | 2026-04-10 | 0 hypotheses

Do these mechanistic hypotheses explain layer-specific synaptic vulnerability in

neurodegeneration | 2026-04-10 | 0 hypotheses

Mechanistic validation of SEA-AD differential expression hypotheses: Complement

neurodegeneration | 2026-04-10 | 0 hypotheses

Unable to extract research questions - transcript appears to be empty

methodology | 2026-04-04 | 2 hypotheses Top: 0.424

How do neurodegeneration gene expression patterns in SEA-AD differ from other po

neurodegeneration | 2026-04-04 | 1 hypotheses Top: 0.534

Which cell types show the most significant expression changes for neurodegenerat

neurodegeneration | 2026-04-03 | 7 hypotheses Top: 0.529

Title & PMID	Authors	Journal	Year	Citations
No papers found

Title & PMID

Authors

Journal

Year

Citations

No papers found

AAD

Understanding Entity Pages

Wiki Pages (5)

Efferocytosis in Neurodegeneration

Section 185: Advanced Heat Shock Protein and Proteostasis Modulation in CBS/PSP

Axon Neuroscience SE

PI-2620 Tau PET Phase 3 (NCT05456503) - FTLD and Atypical AD

UBA1 Protein (E1 Ubiquitin-Activating Enzyme)

Outgoing (0)

Incoming (2)

Targeting Hypotheses (0)

Mentioning Analyses (13)

What are the cell-type-specific transcriptomic signatures of vulnerability in SE

What determines the GPX4/ACSL4 balance that switches microglia from protective t

Which specific cell types show greatest vulnerability in AD based on SEA-AD tran

Do oligodendrocytes require DNA repair enhancement or inhibition for neuroprotec

Do tau aggregates represent protective responses or primary pathogenic drivers i

Is myelin loss in AD causal or an adaptive response to neuronal damage?

What is the optimal ketone dosing threshold to avoid metabolic steal syndrome wh

Do these mechanistic hypotheses from the SEA-AD Atlas bundle explain layer-speci

Do these mechanistic hypotheses explain layer-specific synaptic vulnerability in

Mechanistic validation of SEA-AD differential expression hypotheses: Complement

Unable to extract research questions - transcript appears to be empty

How do neurodegeneration gene expression patterns in SEA-AD differ from other po

Which cell types show the most significant expression changes for neurodegenerat

Related Papers (0)